Molecular studies on COVID-19
Journal of Molecular Biomarkers & Diagnosis is pleased to announce Special issue on “Molecular studies on COVID-19”.
On 31 December 2019 a cluster of cases of pneumonia of unknown etiology was reported to the World Health Organization in Wuhan, China. Subsequent investigations identified a novel corona virus, now known as the severe acute respiratory corona virus 2 syndrome (SARS-CoV-2), from the patients affected. The SARS-CoV-2 genome with a positive-sense, single-stranded RNA genome of ~30 kb in size and encodes ~9,860 amino acids (2, 17, 18, 27). The SARS-CoV-2 genome is arranged in the order of 5'-replicase (ORF1a/b)-spike (S)-envelope (E)-membrane (M)-nucleocapsid (N)-poly(A)-3' (17) just like other betacoronaviruses.
The COVID-19-RdRp/Hel assay was significantly more sensitive to detecting SARSCoV-2 RNA in nasopharyngeal aspirates/swabs or throat swabs, saliva specimens, and plasma specimens than the RdRp-P2 test. The COVID-19-RdRp/Hel assay was highly specific and exhibited no cross-reactivity in vitro and in nasopharyngeal aspirates with other common respiratory pathogens. Using this novel RT-PCR assay could be useful in detecting low-viral COVID-19 cases and in testing patients for upper respiratory tract, saliva, and plasma specimens.
With the same purpose our Journal “Journal of Molecular Biomarkers & Diagnosis” is announcing Special issue Call for paper on “Molecular studies on COVID-19”. We welcome both solicited and unsolicited submissions that will contribute to this special issue.
Please visit Instruction for authors page to know more about article formatting and guidelines: https://www.hilarispublisher.com/molecular-biomarkers-diagnosis/instructionsforauthors.html